Omeros Corporation Gains 41.14%
Fri, Nov 22, 2024 at 07:25 PM
Omeros Corporation (OMER:NASDAQ) shot up at $10.91, representing a gain of 41.1%. On Fri, Nov 22, 2024, OMER:NASDAQ hit a New 2-Week High of $10.91. The stock appeared on our News Catalysts scanner on Fri, Nov 22, 2024 at 03:48 PM in the 'MISCELLANEOUS' category. From Fri, Nov 08, 2024, the stock recorded 40.00% Up Days and 45.45% Green Days
About Omeros Corporation (OMER:NASDAQ)
Omeros Corp is a biopharmaceutical company. It focuses on research and development of small-molecule and protein therapeutics to treat inflammation, coagulopathies, and disorders of the central nervous system and sells Omidria for cataract surgeries.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 243.14%
- Palladyne AI Corp. (PDYN:NASDAQ), 130%
- Nano Labs Ltd (NA:NASDAQ), 89.02%
- SKK Holdings Limited (SKK:NASDAQ), 67.27%
- Wellchange Holdings Company Limited (WCT:NASDAQ), 58.4%
- D-Wave Quantum Inc. (QBTS:NYSE), 48.73%
- Omeros Corporation (OMER:NASDAQ), 41.14%
- Replimune Group, Inc. (REPL:NASDAQ), 35.11%
- Quantum-Si Incorporated (QSI:NASDAQ), 33.88%
- Agrify Corporation (AGFY:NASDAQ), 32.35%